Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:49 AM
Ignite Modification Date:
2025-12-26 @ 11:49 AM
NCT ID:
NCT00515216
Eligibility Criteria:
Inclusion Criteria:
* Patients must have histologically or cytologically confirmed adenocarcinoma of the stomach or gastroesophageal junction.
* Patients must have measurable disease.
* No prior therapy for metastatic disease. Prior neo-adjuvant or adjuvant therapy is permitted if the disease free interval has been longer than 6 months.
* Age ≥18 years.
* Life expectancy of greater than 3 months.
* ECOG (Eastern Cooperative Oncology Group) performance status greater than 2 (Karnofsky greater than 60%).
* Patients must have normal organ and marrow function.
* Not pregnant. Not breast feeding.
* Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:
* Patients may not be receiving any other chemotherapy agents.
* Patients with known active brain metastases. Patients with treated brain metastases are permitted if stable off steroids for at least 30 days.
* History of allergic reactions to 5-FU or oxaliplatin.
* Uncontrolled intercurrent illness.
* Patients with immune deficiency.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00515216
Study Brief:
Protocol Section:
NCT00515216